Desentum Oy

📍 Espoo, Finland🗓 Founded 2011👥 13 employees💰 Last funded Jun 2026
Pharmaceutical Manufacturing🌐 desentum.com
Website LinkedIn
Desentum is a research-oriented, clinical-stage biopharmaceutical company specialized in developing innovative allergen immunotherapy products that are based on switching the immune system’s response to allergens from hypersensitivity to tolerance. The goal is to provide long-term relief for patients suffering from allergic symptoms. Desentum’s product development targets both respiratory and food allergens. Our goal is to provide long-term relief from allergic symptoms with only a few months of treatment, as well as reduce the social and economic burden allergies cause to both individuals and society.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in Desentum Oy?
Desentum Oy has 1 investors on record on gritt.io.
When did Desentum Oy last raise funding?
The most recent investment in Desentum Oy recorded on gritt.io was in June 2026.
When was Desentum Oy founded?
Desentum Oy was founded in 2011.
What industry is Desentum Oy in?
Desentum Oy operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Desentum Oy based?
Desentum Oy is headquartered in Espoo, Finland.